{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:37:41Z","timestamp":1780321061223,"version":"3.54.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1061,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/j.1365-2133.2012.11161.x","type":"journal-article","created":{"date-parts":[[2012,7,21]],"date-time":"2012-07-21T03:02:57Z","timestamp":1342839777000},"page":"1067-1075","source":"Crossref","is-referenced-by-count":15,"title":["Analysis of 303 Ro\/SS-A antibody-positive patients: is this antibody a possible marker for malignancy?"],"prefix":"10.1093","volume":"167","author":[{"given":"B.C.","family":"B\u00f6ckle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Stanarevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ratzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.T.","family":"Sepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,10,5]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/ard.60.5.433","article-title":"Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies","volume":"60","author":"Abu-Shakra","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.11.009","article-title":"A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: inflammation in their induction and impact on tumor growth","volume":"281","author":"Bei","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB3|cit3","first-page":"245","article-title":"Protective autoimmunity in cancer (review)","volume":"17","author":"Toubi","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0961203309102556","article-title":"Lupus and cancer","volume":"18","author":"Gayed","year":"2009","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.23716","article-title":"Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate","volume":"59","author":"Buchbinder","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/art.30134","article-title":"The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan","volume":"63","author":"Chen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/rheumatology\/kep404","article-title":"Incidence of malignancy in primary Sj\u00f6gren\u2019s syndrome in a Chinese cohort","volume":"49","author":"Zhang","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.berh.2008.12.007","article-title":"Malignancy in systemic lupus erythematosus: what have we learned?","volume":"23","author":"Bernatsky","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1471-4906(01)01984-6","article-title":"Antinuclear autoantibodies as potential antineoplastic agents","volume":"22","author":"Torchilin","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF03402004","article-title":"How does autoimmunity cause tumor regression? A potential mechanism involving cross-reaction through epitope mimicry","volume":"8","author":"Sioud","year":"2002","journal-title":"Mol Med"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930400022954","article-title":"Anti-Ro\/SSA and La\/SSB antibodies","volume":"38","author":"Franceschini","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2340\/00015555-0473","article-title":"Clinical follow-up of 102 anti-Ro\/SSA-positive patients with dermatological manifestations","volume":"88","author":"Popovic","year":"2008","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203306073135","article-title":"Fine specificity of the Ro\/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun","volume":"16","author":"Popovic","year":"2007","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.22286","article-title":"A serology-based approach combined with clinical examination of 125 Ro\/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus","volume":"56","author":"Popovic","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00005792-199505000-00001","article-title":"One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up","volume":"74","author":"Simmons-O\u2019Brien","year":"1995","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.2009.09472.x","article-title":"Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients","volume":"162","author":"Vera-Recabarren","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11310780-000000000-00000","article-title":"Cutaneous lupus erythematosus: issues in diagnosis and treatment","volume":"10","author":"Walling","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"issue":"Suppl. 6","key":"10.1111\/j.1365-2133.2012.11161.x-BIB22|cit22","first-page":"S1","article-title":"[AWMF Guideline no. 013\/066 Diagnosis and therapy of circumscribed scleroderma]","volume":"7","author":"Kreuter","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB25|cit25","first-page":"700","article-title":"Incidental cases of subacute cutaneous lupus erythematosus in association with malignancy","volume":"18","author":"Renner","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gr\u00f6nhagen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1002\/1097-0142(19900601)65:11<2554::AID-CNCR2820651126>3.0.CO;2-W","article-title":"Autoantibodies in neoplasia. An unresolved enigma","volume":"65","author":"Swissa","year":"1990","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.2010.28.7078","article-title":"Reduced melanoma after regular sunscreen use: randomized trial follow-up","volume":"29","author":"Green","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00008390-199510000-00005","article-title":"Studies on the expression and immunogenicity of the B50 melanoma antigen and its relationship with calreticulin","volume":"5","author":"Bijwaard","year":"1995","journal-title":"Melanoma Res"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0925-4439(90)90007-C","article-title":"Homology of the B50 murine melanoma antigen to the Ro\/SS-A antigen of human systemic lupus erythematosus and to calcium-binding proteins","volume":"1096","author":"Gersten","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1038\/jid.2009.10","article-title":"Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56","volume":"129","author":"Baek S\u00f8rensen","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11161.x-BIB32|cit32","first-page":"557","article-title":"High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population","volume":"69","author":"Manoussakis","year":"1987","journal-title":"Clin Exp Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.11161.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.11161.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T15:22:57Z","timestamp":1687620177000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/5\/1067\/6614116"}},"subtitle":["Ro\/SS-A antibody as a possible marker for malignancy"],"short-title":[],"issued":{"date-parts":[[2012,10,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11161.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,5]]}}}